Researchers Sequenced Cholera Strains From European Cases
Genetic analysis of 49 cases confirmed the seventh pandemic El Tor lineage, including eight drug-resistant strains.
Updated on Sept. 24, 2026 in Life Sciences
Researchers analyzed 49 Vibrio cholerae O1 isolates collected from European cases reported in 2023 and 2024. The study identified the dominant presence of the seventh pandemic El Tor lineage and characterized specific antimicrobial resistance patterns.
Why it matters
Understanding the phylogenetic relationships and drug resistance profiles of circulating cholera strains is critical for tracking global transmission patterns. The identification of resistant sub-lineages provides public health officials with better data to manage potential outbreaks.
Whole genome sequencing of 49 isolates confirmed they belong to the seventh pandemic El Tor lineage, compared against 1,500 publicly available reference genomes. Researchers identified 33 isolates as the Pre-AFR15 sub-lineage and eight as the drug-resistant AFR13 sub-lineage.
The players
Vibrio cholerae
A bacterium responsible for cholera, tracked globally through its seventh pandemic El Tor lineage.
The details
The analysis utilized whole genome sequencing, a laboratory process that determines the complete DNA sequence of an organism, to characterize the virulence and phylogenetic, or evolutionary, relationships of the isolates. By aligning these 49 genomes against 1,500 existing records of seventh pandemic El Tor, scientists could map the isolates to specific circulating sub-lineages. This method allows researchers to distinguish between regional variants and global pandemic strains at the base-pair level.
Timeline
2023-2024: European countries reported 59 cholera cases.
The Tech Race
This research aligns with the international effort to map the evolution of the seventh pandemic El Tor lineage as it spreads across borders. By maintaining a database of 1,500 reference genomes, the scientific community is building a real-time phylogenetic map to outpace rapid pathogen adaptation.
This research provides clinical and public health data rather than direct consumer tools or products. The findings assist healthcare professionals and diagnostic labs in improving the identification and tracking of resistant pathogens circulating within the region.
The takeaway
This analysis confirms that circulating strains in Europe remain part of the seventh pandemic lineage with concerning pockets of antimicrobial resistance. Public health professionals should watch for future surveillance updates to see if the drug-resistant AFR13 sub-lineage increases in prevalence.
Further reading
For broader context on how genomic monitoring is evolving, see the Life Sciences section.
Source note: This article includes information reported by Biorxiv.
